A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors
Clinical trial NCT04587479 · COMPLETED
Trial details
- NCT number
- NCT04587479
- Sponsor
- Jacobio Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-23
- Primary completion
- 2024-10-31
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.